Dymax to Showcase High-Efficiency, Reliable Adhesion and Curing Solutions for Medical Device Manufacturing at Medical Technology Ireland 2026

September 13, 2026

Dymax USA

Overview

Dymax announced it will showcase efficient and reliable adhesive and curing solutions specifically tailored for medical device manufacturing, including catheter assembly, at Medical Technology Ireland 2026. The company’s innovative portfolio offers precise adhesion control, comprehensive curing validation, and effective curing technologies for hard-to-reach micro-areas. These advancements significantly improve manufacturing efficiency and quality control, ensuring compliance with stringent safety and performance standards for medical devices.

In Depth

Key Findings

Dymax announced its participation in Medical Technology Ireland 2026, held in Ireland from September 10-11, 2026, where it will exhibit high-efficiency and reliable adhesive and curing solutions designed to innovate the manufacturing processes of catheters and other complex medical devices. Dymax’s solutions are poised to dramatically enhance quality control and throughput in medical device manufacturing by enabling precise adhesion, validation of the curing process, and uniform curing even in narrow or hard-to-reach areas.

Technical Details

Dymax’s solutions for medical devices primarily consist of UV/visible light-curable adhesives and corresponding curing equipment. These adhesives are engineered for biocompatibility, low extractables, high strength, and rapid curing characteristics, making them ideal for catheter lumen bonding, balloon attachment, hub assembly, and other critical assembly tasks. Specifically, the company’s UV curing systems deliver light energy with precise wavelengths and intensities, ensuring complete adhesive cure. This minimizes process variability in medical device manufacturing, contributing to improved yields and reduced rework rates. Furthermore, their curing validation systems support compliance with quality control standards (e.g., ISO 13485), ensuring the safety of medical devices.

Background and Industry Context

The medical device industry is subject to extremely high-quality standards and stringent regulatory requirements to ensure patient safety and therapeutic efficacy. Particularly in the assembly of increasingly miniaturized and high-functional medical devices, the precision and reliability of micro-component bonding are paramount. While conventional adhesive methods often presented challenges with curing time and inconsistent adhesive performance, Dymax’s UV/visible light curing technology is gaining attention as a solution that overcomes these hurdles. This enables medical device manufacturers to accelerate market entry for more complex designs and produce high-quality products more cost-effectively.

Strategic Significance and Outlook

Dymax’s exhibition underscores the critical importance of adhesive technology in the future of medical device manufacturing. Moving forward, the company is expected to advance technological developments in areas such as higher automation, IoT integration, and AI-driven curing process control. These advancements will enhance capabilities for personalized medical device production and adaptability to new materials, contributing to innovation in medical technology. Dymax’s solutions are anticipated to continue strongly supporting industry trends toward miniaturization, precision, and enhanced patient safety in medical devices.

Source: https://dymax.com/resources/news-and-media/press-releases/trade-show/dymax-showcases-efficient-and-reliable-medical-device-manufacturing-solutions-at-medical-technology-ireland-2026

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.